Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Hemorrhage Global Market 2016 Prospectus, Examination and Forecast to 2021

Thursday, October 13, 2016 21:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

This report provides comprehensive information on the therapeutic development for Hemorrhage, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhage and special features on late-stage and discontinued projects.


Get Sample Report @


Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.



- The report provides a snapshot of the global therapeutic landscape of Hemorrhage

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Hemorrhage and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Hemorrhage products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Hemorrhage pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products


Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Hemorrhage

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Hemorrhage pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Buy 1-User PDF @


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hemorrhage Overview 6

Therapeutics Development 7

Pipeline Products for Hemorrhage – Overview 7

Pipeline Products for Hemorrhage – Comparative Analysis 8

Hemorrhage – Therapeutics under Development by Companies 9

Hemorrhage – Therapeutics under Investigation by Universities/Institutes 10

Hemorrhage – Pipeline Products Glance 11

Clinical Stage Products 11

Early Stage Products 12

Hemorrhage – Products under Development by Companies 13

Hemorrhage – Products under Investigation by Universities/Institutes 14

Hemorrhage – Companies Involved in Therapeutics Development 15

Cellphire, Inc. 15

Digna Biotech, S.L. 16

Haemostatix Limited 17

QRxPharma Limited 18

Serendex Pharmaceuticals A/S 19

Thrombotargets Europe SL 20

Hemorrhage – Therapeutics Assessment 21

Assessment by Monotherapy Products 21

Assessment by Target 22

Assessment by Mechanism of Action 24

Assessment by Route of Administration 26

Assessment by Molecule Type 28

Drug Profiles 30

DB-055 – Drug Profile 30


Access Report @


Reach Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)           


Follow Us:





Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.